- IRMS - Nicolae Testemitanu SUMPh
- 1. COLECȚIA INSTITUȚIONALĂ
- MedEspera: International Medical Congress for Students and Young Doctors
- MedEspera 2024
Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12710/28795
Title: | Light therapy for seasonal affective disorder (SAD): a meta-analysis of efficacy |
Authors: | Thayyil, Ayisha |
Issue Date: | 2024 |
Publisher: | Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova |
Citation: | THAYYIL, Ayisha. Light therapy for seasonal affective disorder (SAD): a meta-analysis of efficacy. In: MedEspera: the 10th Intern. Medical Congress for Stud. and Young Doctors, 24-27 April 2024: abstract book. Chișinău, 2024, p. 390. ISBN 978-9975-3544-2-4. |
Abstract: | Introduction. Affective Disorder is a growing concern in mental health, and this study explores
the effectiveness of light therapy. This meta-analysis delves into the efficacy of light therapy as a
treatment for SAD. The research illuminates the diverse facets of SAD and its response to light
therapy.
Aim of study. This study explores dynamics of Seasonal Affective Disorder, emphasizing its
connection with seasonal changes and the resulting psychological impact of depression. Going
beyond conventional approaches, it aims to understand how light therapy alleviates associated
depressive symptoms.
Methods and materials. The research is conducted from sources like Google Scholar and
ScienceDirect. Inclusion criteria prioritize studies specifically focused on light therapy for SAD.
Results. To determine the efficacy of light therapy for Seasonal Affective Disorder, a meta-analysis of 19 trials' data was carried out by researchers. With a standardized mean difference for
depression ratings of -0.37 and a risk ratio for treatment response of 1.42, bright light therapy
appears to be superior to placebo. A study presented an innovative perspective by investigating
exposure to outdoor light as a potential adjunct or alternative for traditional artificial light therapy
for SAD. Interestingly, using strong placebo controls to compare white and green light treatments
highlights the difficulties in distinguishing therapeutic benefits from placebos. Furthermore, a
study concentrating on short-wavelength (blue) light treatment shows that it is more effective than
dimmer red light for reducing major depressive disorder symptoms in a seasonal pattern. The meta-analysis contributes valuable insights to the evolving understanding of SAD treatment efficacy
and highlights the need for larger, high-quality clinical trials to further substantiate these findings.
Conclusion. This meta-analysis underscores the significance of light therapy as a viable treatment
for SAD, providing valuable insights into its efficacy. The examination of existing research
enhances our understanding of the role light therapy plays in addressing the psychological aspects
of SAD, paving the way for informed interventions and future studies in this domain. |
metadata.dc.relation.ispartof: | MedEspera: The 10th International Medical Congress for Students and Young Doctors, 24-27 April 2024, Chișinău, Republic of Moldova |
URI: | https://medespera.md/en/books?page=10 http://repository.usmf.md/handle/20.500.12710/28795 |
ISBN: | 978-9975-3544-2-4 |
Appears in Collections: | MedEspera 2024
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|